Julie Rovner, KHN’s chief correspondent in Washington, discussed the FDA approval of a new drug for Alzheimer’s disease on WAMU’s “1A” on Wednesday.
KHN correspondent Aneri Pattani discussed the increase in alcohol consumption and abuse by young women in NPR’s “All Things Considered” on Wednesday.
KHN freelancer Harris Meyer discussed on Tuesday on Newsy and on Wednesday in WCPN’s “The Sound of Ideas” about the approval of a new drug for Alzheimer’s disease by the FDA.
KHN’s social media manager Chaseedaw Giles discussed Lx’s “First Look” on NBC on Tuesday about opioid use and hip-hop music.
KHN (Kaiser Health News) is a national newsroom that produces in-depth journalism on health topics. Together with Policy Analysis and Polling, KHN is one of the three major operational programs of the KFF (Kaiser Family Foundation). KFF is a non-profit foundation that provides the country with information on health issues.
This story can be republished for free (details).